Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2007-04-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation of the Rex Medical -Closer™ Vascular Closure System -Reduced Time to Ambulation Trial
NCT01873898
A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).
NCT02358629
Accelerated Ambulation After Vascular Access Closure Device
NCT03142126
AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)
NCT03573206
Micropuncture vs. Standard Common Femoral Artery Access
NCT02026180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients are asked to walk within 30 minutes after implantation of the Star- Close vascular closure system.
Walking
Patient will walk within 30 minutes of vascular closure system procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Walking
Patient will walk within 30 minutes of vascular closure system procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Catheterization through the femoral artery
* Able to ambulate at least 20 feet
* Able to receive the Star-Close Vascular Closure System
* Be a candidate for hospital discharge following catheterization
Exclusion Criteria
* Blood pressure greater than 180/110
* Pregnant or lactating
* Anemic or low blood count
* Blood thinning medication within 5 days before catheterization
* Unable to walk 20 feet with out rest
* Complications during catheterization procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ernest Mazzaferri
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ernest Mazzaferri
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Earnest L Mazzaferri Jr, MD
Role: PRINCIPAL_INVESTIGATOR
The Ohio State University Medical Center, Division of Cardiovascular Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University Medical Center
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STRUT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.